Evidence map›Paper›PMID 36853461›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

CRISPR/Cas9 Gene Disruption Studies in F

Anita Abu-Daya, Annie Godwin

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anita Abu-DayaEuropean Xenopus Resource Centre, University of Portsmouth, Portsmouth, UK. anita.abu-daya@port.ac.uk.
Annie GodwinEuropean Xenopus Resource Centre, University of Portsmouth, Portsmouth, UK. annie.godwin@port.ac.uk.
University of Portsmouth · GB

Funding

Medical Research Council MR/V012177/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P001009/1
6 · The paper itself

Abstract

CRISPR/Cas9 has become the favorite method for gene knockouts in a range of vertebrate model organisms due to its ease of use and versatility. Gene-specific guide RNAs can be designed to a unique genomic sequence and used to target the Cas9 endonuclease, which causes a double-stranded break at the desired locus. Repair of the breaks through non-homologous end joining often results in the deletion or insertion of several nucleotides, which frequently result in nonsense mutations. Xenopus frogs have long been an excellent model organism in which to study gene function, and they have proven to be useful in gene-editing experiments, especially the diploid species, X. tropicalis. In this chapter, we present our protocols for gene disruption in Xenopus, which we regularly use to investigate developmental processes and model human genetic disease.

Indexed as

AnuraCRISPR-Cas SystemsAnimalsCRISPR-Associated Protein 9DNA End-Joining RepairHumansXenopus laevisCRISPR-Associated Protein 9CRISPR/Cas9Disease modelingGene knockoutMicroCTXenopus laevisXenopus tropicalis

Identifiers

PMID36853461
OpenAlexW4322617575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.